Monoclonal Antibodies to Prevent COVID-19: Phase 3 Clinical Trials Now Enrolling
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults…